The conflicting data reported so far regarding the role Gal-3 in obesity and T2DM suggest that we need of further attention and more clinical studies in order to clarify its role as a potential player and therapeutic target in these conditions. The gene discussed is LGALS3; the disease is obesity due to melanocortin 4 receptor deficiency.